RhumbLine Advisers’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q2 | – | Sell |
-24,195
| Closed | -$2.36M | – | 3180 |
|
|
2015
Q1 | $2.36M | Buy |
24,195
+4,941
| +26% | +$482K | 0.01% | 1292 |
|
|
2014
Q4 | $1.79M | Buy |
19,254
+955
| +5% | +$88.6K | 0.01% | 1429 |
|
|
2014
Q3 | $1.26M | Sell |
18,299
-1,330
| -7% | -$91.5K | ﹤0.01% | 1609 |
|
|
2014
Q2 | $2.06M | Buy |
19,629
+2,532
| +15% | +$265K | 0.01% | 1353 |
|
|
2014
Q1 | $1.42M | Buy |
17,097
+80
| +0.5% | +$6.64K | ﹤0.01% | 1571 |
|
|
2013
Q4 | $1.1M | Buy |
17,017
+1,570
| +10% | +$102K | ﹤0.01% | 1748 |
|
|
2013
Q3 | $978K | Sell |
15,447
-43
| -0.3% | -$2.72K | ﹤0.01% | 1796 |
|
|
2013
Q2 | $651K | Buy |
+15,490
| New | +$651K | ﹤0.01% | 2067 |
|